Ascletis Pharma Inc.

Investors

Financials & Filing

2025

2024

2023

2022

2021

2020

2019

2018

Notification Letter to Non-Registered Holders of Shares with Request Form - Notice of Publication of Circular containing Notice of Annual General Meeting
2019-05-06
Form of Proxy for the 2019 Annual General Meeting
2019-05-06
Notice of 2019 Annual General Meeting
2019-05-06
Proposals for General Mandates to Issue Shares and to Repurchase Shares, Re-election of Directors and Notice of Annual General Meeting
2019-05-06
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2019
2019-05-06
Voluntary Announcement - Dosing in Phase 2 Clinical Trial of the FASN Inhibitor TVB-2640 in Patients with NASH
2019-05-02
Notification Letter to Non-Registered Holders of Shares with Request Form - Notice of Publication of Annual Report 2018
2019-04-24
2018 Annual Report
2019-04-24
Voluntary Announcement - Ganovo is Eligible for the Basic Medical Insurance of Zhejiang Province - Reimbursement-by-disease
2019-04-15
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2019
2019-04-04

4

© 2018 Ascletis Pharma Inc. All Rights Reserved
浙公网安备 33010802003344号浙ICP备11050387号-1